Key Considerations when Implementing a Decentralized Clinical Trial

Presented by:

  • Free

Why attend?

The popularity of decentralized clinical trials (DCTs) is surging—especially among patients. Harnessing technology of all kinds, these trials provide an attractive alternative to the old-style site-anchored system on which traditional clinical trials have rested. They also have the potential to provide better, more timely data, since that data is largely collected under real-life situations and often available more quickly to monitoring teams.

With patients insisting on the convenience and control DCTs give them, there is a growing imperative for researchers to adopt new methods of data management. Fortunately, technology holds an answer there, too. Please join us to discuss the key considerations for running a DCT.

Key Learning Objectives

  • How to appropriately prepare and plan for a DCT
  • Key considerations for selecting DCT sites
  • How to manage and mitigate risks associated with DCTs
  • What type of technologies should you be considering to be successful with a DCT

Target Audience

  • Director
  • Senior Director
  • VP
  • Head
  • Executive Director


Select a speaker to learn more

Kristin Mauri
Director of Solutions Services, Remarque Systems

Kristin Mauri is Director of Solution Services at Remarque Systems. Ms. Mauri brings more than 25 years of clinical research experience and eClinical technology implementation for pharma, biotech, and CRO organizations. Prior to joining Remarque Systems, Ms. Mauri was Global Head of Risk Based Monitoring at BioClinica, where she was responsible for overseeing the RBM technology and services practice. A recognized thought leader and industry speaker, Ms. Mauri has presented extensively on clinical operations topics in the areas of Risk Based Monitoring, Quality Management, and Clinical Trial Forecasting and Budgeting. Ms. Mauri’s educational credentials include an MBA from Lake Forest Graduate School of Management, MGH Boston master’s program coursework in Clinical Investigations, and a bachelor’s degree from Pennsylvania State University.

Next speaker
Adam Samson, MS, PMP, CCRA, CCRC, CCDM
Senior Director of Clinical Operations & Customer Success, Curebase

For over a decade, Mr. Samson has conducted clinical trials across multiple therapeutic areas as a coordinator, monitor, project manager, and director within academia, sites, CROs, pharma, and tech. He currently serves as Senior Director of Clinical Operations & Customer Success at Curebase, a software and services provider purpose-built for decentralized clinical trials (DCT). Mr. Samson also serves as adjunct faculty at The George Washington University in the Master’s in Clinical Research Administration program. Every day, he leverages his wide-ranging experience to tackle the most pressing challenges related to operationalizing DCTs. In doing so, Mr. Samson and his team are among a select number of individuals who have done enough in-the-trenches work to understand current best practices in the DCT space.

Next speaker

Contact us

If you want to become a sponsor, speak at an event or become a partner, leave a message at the "Partner with us" page and we will contact you as soon as possible.